A CD8+ T cell signature has traditionally marked good prognosis in many types of cancers (45), but it is only more recently that we are beginning to appreciate the great complexity of T cell subpopulations inhabiting the tumor stroma and the infiltrating lymph nodes. The gene discussed is CD8A; the disease is neoplasm.